| 000 | 00765 a2200217 4500 | ||
|---|---|---|---|
| 005 | 20120627122852.0 | ||
| 008 | 120627t xxu||||| |||| 00| 0 eng d | ||
| 080 |
_a575.111:615 _bMIS |
||
| 100 |
_aMisra, Ambikanandan; ed. _eed.by _920744 |
||
| 245 | _aChallenges in delivery of therapeutic genomics and proteomics | ||
| 300 | _axiv, 671p. | ||
| 490 | _aElesevier insights series | ||
| 653 | _aPharmaceutical biotechnology | ||
| 653 | _aGeomics-gene therapy | ||
| 653 | _aProtein drugs | ||
| 653 | _aProteomics | ||
| 942 | _cBK | ||
| 260 |
_bElsevier _c2011 _aMassachusetts _920745 |
||
| 020 | _a9780123849649 | ||
| 952 |
_w2012-01-18 _p00066953 _v0.00 _r2012-01-18 _40 _e117 _00 _bUL _10 _o575.111:615 MIS _d2012-01-18 _70 _cGEN _2udc _g0.00 _yBK _aUL |
||
| 999 |
_c73342 _d73341 |
||